Brief: Sensei Biotherapeutics Reports Second Quarter 2022 Financial Results
09/08/2022 12:39
Aug 9 (Reuters) - Sensei Biotherapeutics Inc SNSE.O :
* SENSEI BIOTHERAPEUTICS REPORTS SECOND QUARTER 2022
FINANCIAL
RESULTS AND RECENT BUSINESS HIGHLIGHTS
* SENSEI BIOTHERAPEUTICS INC - STRONG BALANCE SHEET WITH
CASH
RUNWAY INTO Q1 OF 2025
* SENSEI BIOTHERAPEUTICS INC QTRLY NET LOSS PER SHARE, BASIC
AND
DILUTED $0.34
Source text for Eikon: ID:nGNX4700Sy
Further company coverage: SNSE.O
Recent news on Faeth Therapeutics,
See all newsBrief: Sensei Biotherapeutics Announces Name Change To Faeth Therapeutics
Brief: Sensei Biotherapeutics Doses First Patient In Phase 1B/2 Trial Of Piktor In Hr+/Her2- Advanced Breast Cancer
Brief: Sensei Biotherapeutics Reports Full Year 2025 Financial Results And Provides Corporate Update
Brief: Sensei Biotherapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Brief: Sensei Biotherapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)